EquiReason

EquiReason research coverage

Sight Sciences, Inc. SGHT

Healthcare · Medical Instruments & Supplies

24quarters analysed
12SEC filings read
2segments identified
12institutional managers tracked

Segments it reports

The business segments Sight Sciences, Inc. reports in its own SEC filings.

  • Surgical Glaucoma
  • Dry Eye

What we read

The sources behind this company, and how many records of each we hold.

  • Financial statements26
  • Quarterly metric series12
  • Business segments2
  • SEC filings12
  • Insider transactions (Form 4)6
  • Institutional positions (13F)7
  • Earnings quality checks5
  • Estimate revisions11
  • GAAP vs non-GAAP reconciliation1
  • Seasonal pattern6
  • Multi-period trajectory7
  • Inflection detection1
  • Fiscal calendar1
  • Index membership4

What we look for

Every company is run through the same checks. Both answers are reported — a signal we looked for and did not find is as much a fact as one we did.

  • Revenue series24
  • Margin series12
  • Cash flow series23
  • Earnings series24
  • Operating cash flow series24
  • Guidance changesnot found
  • Per-share seriesnot found

This page says how much of Sight Sciences, Inc. we have read. What any of it means — the direction, the dates, the evidence and what would overturn it — is inside the product.

Open SGHT in EquiReason

This page publishes coverage counts and reported breakdown names, but no financial figures, price data, rankings or investment conclusions. Sources are SEC filings, earnings calls and public institutional disclosures. How the research is made · All companies

Sight Sciences, Inc. (SGHT) — research coverage | EquiReason